Yokogawa Releases AI-enabled Versions of SMARTDAC+ Paperless Recorders and Data Logging Software, and Environmentally Robust AI-enabled e-RT3 Plus Edge Computing Platform for Industry Applications

 Yokogawa Releases AI-enabled Versions of SMARTDAC+ Paperless Recorders and Data Logging Software, and Environmentally Robust AI-enabled e-RT3 Plus Edge Computing Platform for Industry Applications

 –Use of AI to detect problems at an early stage and enhance productivity–

Yokogawa Electric Corporation (TOKYO: 6841) announces the release of artificial intelligence (AI)-enabled versions of the GX series panel-mount type paperless recorders, GP series portable paperless recorders, and GA10 data logging software, which are components of the highly operable and expandable SMARTDAC+TM data acquisition and control system. This new AI functionality includes the future pen, a function developed by Yokogawa that enables the drawing of predicted waveforms. Yokogawa is also releasing a new CPU module for the e-RT3TM Plus edge computing platform that is environmentally robust and PythonTM*1 compatible. The GX/GP and e-RT3 Plus release is set for April 8, and the GA10 software will be released on May 13. The SMARTDAC+ system is a product in the OpreXTM Data Acquisition family, and the e-RT3 Plus is part of the OpreX Control Devices family.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200407005269/en/

(top) GA10 display (bottom left to right) e-RT3 Plus and GX/GP (Graphic:Yokogawa Electric Corporation)

(top) GA10 display (bottom left to right) e-RT3 Plus and GX/GP (Graphic:Yokogawa Electric Corporation)

The introduction of AI functions such as the future pen, a first for industrial recorders*2, will help users identify and correct problems before they have a chance to cause disruptions in production operations.


There is a rising interest in the manufacturing sector in the use of AI to prevent equipment malfunctions and maximize productivity. At the same time, AI technologies have a steep learning curve, and the introduction of existing AI-enabled products and the analysis of their data is typically beyond the expertise of novices to this field.

Recorders are used in manufacturing and R&D to acquire, display, and record data on voltage, current, temperature, flow rate, pressure, and other process variables. Yokogawa is a leading manufacturer of recorders, and also holds a solid track record in the consulting industry with the use of machine learning to predict and analyze both equipment anomalies and product quality for manufacturers. To improve productivity and product quality, Yokogawa is now building user-friendly AI-related functions into its recorders, data logging software, and controllers. For example, these functions now enable GX/GP series recorders to draw waveforms on screen that are predicted based on the real-time analysis of collected data so that users can anticipate and correct problems early on, before they have a chance to escalate. Also, the e-RT3 Plus edge computing platform has been enhanced with the addition of support for Python, a programming language that is widely used in AI R&D.


  1. AI future pen function for drawing of predicted waveforms

    A future pen function has been added to the GX/GP series recorders to enable the drawing of predicted waveforms based on the use of AI to analyze collected data in real time. By viewing predicted waveforms up to a specified time point, users can identify the likelihood that an alarm will occur and take action in advance. An industry first, this adds an entirely new dimension to the capabilities of recorders, whose collection and recording of data has conventionally been used to visualize the past and present performance of various types of equipment.

  2. Detection of anomalies and prediction of potential failures

    A machine learning function has been added to the GA10 data logging software that can acquire normal process values from correctly operating devices and use these values to detect an anomaly and predict a potential failure, a capability that up till now has only been possessed by the most expert operators. Data on which device is expected to fail is displayed on screen, highlighted within a yellow frame. Maintenance can thus be performed before the device fails, minimizing the likelihood of any disruptions to production. This function does not necessitate the collection of abnormal process values and thus is easy to implement.

  3. Addition of Python support

    e-RT3 Plus controllers can be built into various types of devices. For use with these controllers, Yokogawa is releasing a new CPU module that supports Python, a programming language that is widely used in machine learning and other branches of the AI field. The large library of software written in this language includes numerous tools that programmers can use to speed up their development of AI predictive diagnostic functions. This new CPU module also has excellent environmental resistance, and easily accommodates existing input/output (IO) modules. The addition of this new module to the e-RT3 Plus edge computing platform will enable the introduction of AI solutions in a wider range of industries.

For added flexibility, the new e-RT3 Plus controllers run on Linux Ubuntu*3, a general-purpose operating system.

Major Target Markets

GX series: Production sites in a wide range of industries including iron and steel, electric power, chemicals, pulp and paper, foods, pharmaceuticals, heat treatment equipment, water supply and wastewater treatment, electrical equipment, and electronics

GP series: Companies engaged in R&D of home appliances, automobiles, semiconductors, and new-energy related technologies as well as academic institutions and research institutes

GA10: Both of the above

e-RT3 Plus: Manufacturers of industrial machinery and companies engaged in the assembly of electronic components and devices


Monitoring and recording of voltage, current, temperature, flow rate, pressure, and other process variables; evaluation of performance in equipment management, production, and product development; safety and reliability evaluation during product quality inspection processes

*1 A versatile programming language that is widely used in AI application development. Designed to be user-friendly with simple code, Python enables users to write various programs in a clear manner with fewer lines of code than other languages. In addition, numerous Python open-source libraries are available for use in machine learning and other AI applications.

*2 Based on a March 2020 Yokogawa survey

*3 A Linux distribution and installation package provided by Canonical Ltd., a UK-based software company


SMARTDAC+ stands for smart data acquisition and control, and the SMARTDAC+ system includes a variety of IO modules and options. With the product lineup of the GX series panel-mount type paperless recorders, GP series portable paperless recorders, GA10 data logging software, and GM series data acquisition systems, SMARTDAC+ offers extensive support for manufacturing process monitoring and performance evaluation.

For more information


About OpreX

OpreX is the comprehensive brand for Yokogawa’s industrial automation (IA) and control business. The OpreX name stands for excellence in the technologies and solutions that Yokogawa cultivates through the co-creation of value with its customers, and encompasses the entire range of Yokogawa’s IA products, services, and solutions. This brand comprises the following five categories: OpreX Transformation, OpreX Control, OpreX Measurement, OpreX Execution, and OpreX Lifecycle. The SMARTDAC+ data acquisition and control system is part of the OpreX Data Acquisition lineup, which is aligned under the OpreX Measurement category. The OpreX Measurement category includes field equipment and systems for highly precise measurement, data collection, and analysis.

With this brand, Yokogawa will deliver integrated solutions that address specific needs and support its customers in their efforts to transform and grow their businesses.

About Yokogawa

Founded in 1915, Yokogawa engages in broad-ranging activities in the areas of measurement, control, and information. The industrial automation business provides vital products, services, and solutions to a diverse range of process industries including oil, chemicals, natural gas, power, iron and steel, and pulp and paper. With the life innovation business, the company aims to radically improve productivity across the pharmaceutical and food industry value chains. The test & measurement, aviation, and other businesses continue to provide essential instruments and equipment with industry-leading precision and reliability. Yokogawa co-innovates with its customers through a global network of 113 companies spanning 60 countries, generating US$3.6 billion in sales in FY2018. For more information, please visit www.yokogawa.com .

The names of corporations, organizations, products, services and logos herein are either registered trademarks or trademarks of Yokogawa Electric Corporation or their respective holders.

Yokogawa Electric Corporation

Public Relations, Integrated Communications Center


KEYWORDS: Japan Asia Pacific

INDUSTRY KEYWORDS: Data Management Technology Manufacturing Other Technology Software Other Manufacturing Hardware


(top) GA10 display (bottom left to right) e-RT3 Plus and GX/GP (Graphic:Yokogawa Electric Corporation)

Vonage’s Video API Experiences High Demand as Need for Remote Work, Telehealth and Online Education Grows in Light of Public Health Crisis

Vonage’s Video API Experiences High Demand as Need for Remote Work, Telehealth and Online Education Grows in Light of Public Health Crisis

Company extends free, unlimited use of Vonage Video Conferencing for businesses and consumers throughout 2020 in response to this demand

HOLMDEL, N. J.–(BUSINESS WIRE)–Vonage (Nasdaq: VG), a global business cloud communications leader, announced that it has extended the availability of its free desktop and mobile video collaboration product, Vonage Video Conferencing (VVC), until the end of the year. VVC, and Vonage’s complete suite of video communication solutions, address the growing need for people to stay connected during the global health crisis.

Vonage’s video has been a worldwide leader in webRTC video solutions since the webRTC standard was established in 2012. Vonage Video Conferencing is built on Vonage’s Video API, which enables any organisation to embed video capabilities into any software or service that needs it.

Vonage’s Video API has experienced significant growth over the last three months, especially in the telehealth, social and education verticals, and has delivered more than 50 billion minutes of video since inception, across a virtually unlimited number of use cases.

Get Medical Advice from Anywhere with Vonage

In addition to powering the free Vonage Video Conferencing solution and Vonage Meetings, Vonage’s Video API powers leading telemedicine companies. With healthcare facilities stretched to capacity, there is a growing need for video solutions to help the healthcare community respond to patients’ needs and deliver the care they deserve – without putting providers and patients at unnecessary risk.

“While video conferencing has been in the headlines of late, the growth in video-based applications is even more important. In particular, video-based applications are powering essential telehealth services during this public health crisis,” said Alan Masarek, Vonage CEO. “With a long history as a leader in video, Vonage powers the solutions of many of the world’s leading telehealth services including Teladoc, Babylon Healthcare, InTouch Health, Sanvello Health, DocPlanner Group, Doctolib and others.”

Use Vonage Video Conferencing From Your Desktop and Mobile Device for Face-to-Face Communication Anywhere

With Vonage Video Conferencing, organisations get high quality, easy-to-use desktop and mobile video connectivity. Vonage Video Conferencing users don’t need to be Vonage customers, sign a contract, see third-party advertising, or even register for the service to leverage its video capabilities.

Unlike other free video services, Vonage Video Conferencing is easy to use and available in seconds with:

● Desktop and Mobile Web Support

● No registration

● No downloads

● No maximum number of meetings

● No meeting time limits

Vonage’s Video API also powers the Company’s existing desktop and mobile video collaboration service, Vonage Meetings, which is built into the Vonage Business Communications unified communications solution. However, for organisations that may not need a complete cloud solution right now, Vonage Video Conferencing is a great alternative to keep people connected during this time of great need.

Vonage Video Conferencing Keeps Families Connected

Recognising that video is critical to keeping people connected with family and friends, the company has made Vonage Video Conferencing available to its 1 million home phone service customers, in addition to the general public. Anyone who wants to use the service can simply open their web browser from a computer or mobile device and go to https://freeconferencing.vonage.com/ to be on a video conference in seconds. A simple how-to guide is also available on the website.

Availability and Security is Critical

During this large scale move to remote work across the globe, service availability, security and privacy remain a top priority. Vonage video incorporates industry best practices in these areas including:

● Software and infrastructure designed with high availability on geo-redundant public cloud technology, with the ability to scale to meet increases in usage and bandwidth demand;

● A microservices architecture with robust monitoring to ensure a real-time view of performance;

● State-of-the-art monitoring tools and technologies, a 24×7 Network Operations Centre, and a global workforce to ensure the availability of 24×7 expert engineers to support customers globally; and

● The same underlying communications APIs that have been leveraged by developers around the world to build HIPAA and GDPR-compliant video solutions.

About Vonage

Vonage is redefining business communications once again. We’re making communications more flexible, intelligent, and personal, to help enterprises the world over, stay ahead. We provide unified communications, contact centres and programmable communications APIs, built on the world’s most flexible cloud communications platform. True to our roots as a technology disruptor, our flexible approach helps us to better serve the growing collaboration, communications, and customer experience needs of companies, across all communications channels. Vonage Holdings Corp. is headquartered in New Jersey, with offices throughout the United States, Europe, Israel, Australia and Asia. To follow Vonage on Twitter, please visit twitter.com/vonage. To become a fan on Facebook, go to facebook.com/vonage. To subscribe on YouTube, visit youtube.com/vonage.


Jo Ann Tizzano




Hunter Blankenbaker



KEYWORDS: Australia Germany North America Europe United States France United Kingdom Australia/Oceania New Jersey

INDUSTRY KEYWORDS: Telecommunications Software Other Communications Audio/Video Data Management Communications Technology Mobile/Wireless



Bank Otkritie first financial company in Russia to harness 32G FC with ADVA FSP 3000

Bank Otkritie first financial company in Russia to harness 32G FC with ADVA FSP 3000

Compact DCI solution also features ADVA’s OpenFabric™ OTN cross-connect and ALM fiber monitoring technology

ADVA (FSE: ADV) today announced that Bank Otkritie has deployed its FSP 3000 to enable 32Gbit/s Fibre Channel as well as 40 and 100Gbit/s Ethernet services. One of Russia’s largest commercial financial companies, Bank Otkritie is the first bank in the country to leverage Gen 6 Fibre Channel technology. Featuring the ADVA OpenFabric™ OTN cross-connect for enhanced availability, the data center interconnect (DCI) solution delivers a new level of capacity and reliability. Comprehensive, in-service assurance and rapid failure detection capabilities are provided by the ADVA ALM fiber monitoring system. ADVA’s Select partner, the IT solution specialist Zettaline, also played a key role in facilitating the project.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200407005043/en/

ADVA's playing a key role in helping Bank Otkritie transport its mission-critical data (Photo: Business Wire)

ADVA’s playing a key role in helping Bank Otkritie transport its mission-critical data (Photo: Business Wire)

“As one of Russia’s leading banks, it’s vital that we provide our customers with continuous access to their mission-critical financial data. That’s why the ADVA FSP 3000 combined with OpenFabric™ and ALM assurance technology is the ideal tool. It ensures comprehensive monitoring and testing for the highest network availability and service reliability,” said Andrey Ivashenko, VP and CIO, Bank Otkritie. “By supporting 32Gbit/s Fibre Channel, this new solution has taken our storage data transport to the next stage. And, with the ADVA FSP 3000 OpenFabric™ aggregating lower-speed services onto high-speed wavelengths, we have the power to efficiently provide the data rates that our individual customers require.”

Built on the ADVA FSP 3000, a uniquely compact and efficient optical transport solution, Bank Otkritie’s new DCI network saves significantly on opex. The infrastructure delivers high-capacity Ethernet and Fibre Channel connectivity while consuming extremely low levels of power, helping Bank Otkritie to hit ambitious energy targets even as traffic continues to grow. Featuring ADVA’s OpenFabric™ OTN cross-connect, the new solution also offers ultimate flexibility, enabling services to be turned up remotely and easily. What’s more, the scalable modular design of the platform protects Bank Otkritie’s investment and empowers the company to plan for further expansion.

“Bank Otkritie’s new network provides a significant boost in terms of capacity and efficiency. With our FSP 3000 technology, it supports the most advanced low-latency Fibre Channel services, enabling the bank to maximize the performance of flash-enhanced storage in its data centers,” commented Andreas Jelinek, senior director, sales, Eastern Europe, Russia and CIS, ADVA. “Robustness and reliability were key to this project. That’s why Bank Otkritie also selected our ALM solution. Specifically engineered to be a simple plug-and-play fiber assurance device, it provides continuous monitoring, enabling operators to know immediately if and where issues arise. This real-time data is key to supervising and assuring dark fiber services. And, in the event of any fiber issues, our FSP 3000 OpenFabric™ automatically discovers new paths, enhancing availability and quality of service.”

About ADVA

ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com.

Published by:

ADVA Optical Networking SE, Munich, Germany


For press:

Gareth Spence

t +44 1904 699 358


For investors:

Stephan Rettenberger

t +49 89 890 665 854


KEYWORDS: Russia Europe

INDUSTRY KEYWORDS: Data Management Technology Professional Services Security Telecommunications Software Networks Internet Mobile/Wireless Hardware Finance


ADVA’s playing a key role in helping Bank Otkritie transport its mission-critical data (Photo: Business Wire)

GOGL – Appointment of CEO

The Board of Golden Ocean Group Limited (“Golden Ocean” or the “Company”) is pleased to announce the appointment of Ulrik Uhrenfeldt Andersen as the new Chief Executive Officer of Golden Ocean Management AS with effect from Tuesday April 14, 2020.

Mr Andersen comes from a position as Chief Executive Officer of Avance Gas AS and previously worked as Head of Shipping for Petredec, Managing Director for Neu Gas Shipping and Head of the Maersk VLGC Pool.

Ola Lorentzon, Chairman of the Board, says: “The Board is delighted to have appointed Ulrik Andersen, who has demonstrated strong management skills and strategic insight in his previous job as CEO of Avance Gas. We are confident Ulrik will move the Company forward and capitalise on the opportunities that lie ahead. On behalf of the Board, I welcome Ulrik to Golden Ocean and look forward to working with him.”

On being appointed, the incoming CEO stated: “I am excited to be joining Golden Ocean and look forward to working with the strong organisation to drive the business forward in the years to come. Strong foundations have already been laid and I welcome the opportunity to build on these and to explore new opportunities for growth and consolidation.”


About the Company

Golden Ocean is a leading international dry bulk shipping company founded in 1996 and based in Bermuda. Golden Ocean is mainly operating in the Capesize, Panamax and Supramax segments and the Company is listed on NASDAQ and the Oslo Stock Exchange. The Company owns and controls a fleet of 79 vessels.


April 7, 2020

The Board of Directors
Golden Ocean Group Ltd.
Hamilton, Bermuda


For further queries, please contact:

Per Heiberg: Chief Financial Officer, Golden Ocean Management AS
+47 22 01 73 45

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act


Ahold Delhaize share buyback update

Zaandam, the Netherlands, April 7, 2020 – Ahold Delhaize has repurchased 700,000 of Ahold Delhaize common shares in the period from March 30, 2020 up to and including April 3, 2020. The shares were repurchased at an average price of €21.36 per share for a total consideration of €14.9 million. These repurchases were made as part of the €1 billion share buyback program announced on December 4, 2019.

The total number of shares repurchased under this program to date is 16,407,507 common shares for a total consideration of €348.7 million.

Download the share buyback transactions excel sheet for detailed individual transaction information from www.aholddelhaize.com/en/investors/share-information/share-buy-back-programs/

This press release is issued in connection with the disclosure and reporting obligation set out in Article 2(2) of the EU Regulation that contains technical standards for buyback programs.

Ahold Delhaize and local brands deploy more than €170 million on COVID-19 care to meet associate, customer, and community needs

Zaandam, the Netherlands, April 7, 2020 – Ahold Delhaize announces today that together with its local brands, it has deployed more than €170 million on COVID-19 relief and support efforts so far. These efforts range from health and safety measures for associates and customers, to enhanced benefits for frontline associates, to charitable donations to support local communities.

“In this time of acute need we see people coming together across all our communities to help each other through this pandemic,” said Frans Muller, Ahold Delhaize President and CEO. “Ahold Delhaize and all our local brands in the U.S., Europe, and Indonesia are taking substantial measures to ensure the safety of both associates and customers in response to the significant challenges created by the COVID-19 pandemic. Fighting this requires everyone’s support and I am pleased with our efforts to date.”

Muller continued, “I want to recognize the resilience and courage demonstrated by all the medical and emergency professionals working on the front line. Our own sector has also proven to be vital at this time – supported by associates across all our brands, in our supply chains, and at our support offices. Their determined efforts and the care and teamwork they exhibit every day fill me with pride. I am both impressed and humbled by their actions in this time of great need. Finally, I am grateful to customers in all the communities we serve for respecting social distancing guidelines and local health regulations that help protect not only themselves but our associates as well.”

Fighting COVID-19 is requiring all these efforts and more, including the following actions already taken:

For associates

  • To further safeguard associate health, local brands across Ahold Delhaize have introduced additional safety and protective measures for associates, totaling €44 million. Among the protective measures included are plexiglass shields at registers and new store flow patterns to maintain social distancing.
  • Local brands in the U.S., Europe, and Indonesia are recognizing the considerable and exceptional efforts associates are taking by enhancing pay and / or associate benefits.
  • Ahold Delhaize brands are providing further economic support to communities, with their combined commitments to hire more than 40,000 associates. Local brands are liaising especially with displaced people in industries that have been heavily affected by the COVID-19 pandemic, such as travel, tourism, and hospitality.
  • Local brands across Ahold Delhaize have also enhanced associate assistance programs to provide health and wellbeing support.

For customers

  • All local brands across Ahold Delhaize have introduced new in-store signage and other markers to help customers cooperate in maintaining social distancing protocols.
  • Across the U.S. and Europe, our brands have introduced special opening hours for the elderly and other vulnerable populations as well as essential personnel who are responding to the crisis.
  • Some brands have also established special grocery delivery services for healthcare workers.
  • Local brands have further enhanced already stringent cleaning and hygiene measures, like cart cleaning before and after use.

For communities

  • Collectively, the Ahold Delhaize brands have so far committed nearly €20 million to charitable donations to support the following: local food banks, feeding first responders in critically hard-hit areas, national and private health systems, the Red Cross, and to medical facilities to further research on COVID-19. 

Cautionary notice

This communication includes forward-looking statements. All statements other than statements of historical facts may be forward-looking statements. Words such as so far, through, ensure, further, maintain or other similar words or expressions are typically used to identify forward-looking statements.

Forward-looking statements are subject to risks, uncertainties and other factors that are difficult to predict and that may cause actual results of Koninklijke Ahold Delhaize N.V. (the “Company”) to differ materially from future results expressed or implied by such forward-looking statements. Such factors include, but are not limited to, the risk factors set forth in the Company’s public filings and other disclosures. Forward-looking statements reflect the current views of the Company’s management and assumptions based on information currently available to the Company’s management. Forward-looking statements speak only as of the date they are made and the Company does not assume any obligation to update such statements, except as required by law.

Falcon Oil & Gas Ltd. – Beetaloo Farm-Out

Falcon Oil & Gas Ltd.


Beetaloo Farm-Out

7 April 2020  – Falcon Oil & Gas Ltd. (TSXV: FO, AIM: FOG) (“Falcon”) is pleased to announce that its c. 98% subsidiary, Falcon Oil & Gas Australia Limited (“FalconAustralia”), has executed an agreement which includes a restated Farm-Out Agreement and Joint Operating Agreement (collectively “the Agreements”) with Origin Energy B2 Pty Ltd., a subsidiary of Origin Energy Limited (“Origin”) to farm down 7.5% of Falcon Australia’s 30% participating interest (“PI”) in the Exploration Permits in the Beetaloo Sub-basin, Northern Territory, Australia (“the Permits”). Falcon and Origin are obligated to seek the Northern Territory government and TSXV stock exchange approvals, in respect of the Agreements.

Transaction details

  • With the necessary approvals, the PI of the respective JV partners will be:
    • Falcon Australia 22.5%
    • Origin 77.5%
  • In consideration of Falcon Australia transferring 7.5% of its PI, Origin will increase the gross cost cap of the work program by A$150.5 million.
  • The previous farm-in arrangement included a Stage 2 gross cost cap of A$65.3 million and a Stage 3 gross cost cap of A$48 million, or A$113.3 million in total. Under the Agreements, the Stage 2 and Stage 3 gross cost caps will be combined and increased by A$150.5 million to A$263.8 million (the “Overall Cost Cap”),
  • This Overall Cost Cap will be applied to the completion of the Stage 2 and Stage 3 work programmes.
  • Amounts of the Overall Cost Cap not utilised during Stage 2 and Stage 3 will be applied to future work programmes.
  • Expenditure above the Overall Cost Cap will be borne by the JV partners in proportion to their PI.
  • Origin will assume 25% of the cost of Falcon Australia’s remaining call option to reduce the overriding royalties with the TOG Group. The cost to Falcon Australia, should it wish to exercise the call option, will reduce from US$7.5 million to US$5.625 million, in line with its reduced PI.  

Operational Update

Drilling operations on the Kyalla 117 N2-1H ST2 well (“Kyalla Well”) were successfully completed in February 2020, reaching a total measured depth of 3,809 metres, including a 1,579-metre lateral section (from 90 degrees) in the Lower Kyalla Formation. Water impact monitoring bore drilling was completed in March and final preparatory work continues ahead of the next stage of operations. On 26 March, in response to the COVID-19 pandemic, Origin confirmed forward operations in the Beetaloo had been temporarily paused. As a result, Origin expects a delay to the Kyalla Well stimulation and extended production test of at least 3 months to now occur in H2 2020, and the drilling of the Velkerri Flank well in H1 2021.

Philip O’Quigley, CEO of Falcon commented:

“Falcon Australia’s farm down of 7.5% of its PI in the Permits for a further gross cost cap of A$150.5 million, provides Falcon with additional funding that can be applied to the completion of the Stage 2 and Stage 3 work programmes. It also demonstrates Origin’s continued commitment to the Beetaloo Sub-basin. This farm down together with Falcon’s unaudited cash reserves of US$11.5 million at 31 March 2020 leaves us well positioned to participate in the future upside potential of the Beetaloo. We look forward to updating the market as soon as operations recommence in the Beetaloo.”



Falcon Oil & Gas Ltd.   +353 1 676 8702
Philip O’Quigley, CEO +353 87 814 7042
Anne Flynn, CFO +353 1 676 9162
Cenkos Securities plc (NOMAD & Broker)  
Neil McDonald / Derrick Lee +44 131 220 9771

This announcement has been reviewed by Dr. Gábor Bada, Falcon Oil & Gas Ltd’s Head of Technical Operations. Dr. Bada obtained his geology degree at the Eötvös L. University in Budapest, Hungary and his PhD at the Vrije Universiteit Amsterdam, the Netherlands. He is a member of AAPG.

About Falcon Oil & Gas Ltd.

Falcon Oil & Gas Ltd is an international oil & gas company engaged in the exploration and development of unconventional oil and gas assets, with the current portfolio focused in Australia, South Africa and Hungary. Falcon Oil & Gas Ltd is incorporated in British Columbia, Canada and headquartered in Dublin, Ireland with a technical team based in Budapest, Hungary.

Falcon Oil & Gas Australia Limited is a c. 98% subsidiary of Falcon Oil & Gas Ltd.

For further information on Falcon Oil & Gas Ltd. please visit www.falconoilandgas.com

This announcement contains inside information.

About Origin Energy

Origin Energy (ASX: ORG) is a leading Australian integrated energy company. Origin is a leading energy retailer with approximately 4.1 million customer accounts, has approximately 6,000 MW of power generation capacity and is also a large natural gas supplier. Origin is the upstream operator of Australia Pacific LNG, which supplies natural gas to domestic markets and exports LNG under long term contracts.


Glossary of terms

A$ Australian dollar
Cost Cap The costs up to which Origin has agreed to fund 100%. Any costs incurred above the Cost Cap will be paid 77.5% by Origin and 22.5% by Falcon Australia
H1 First six months of the calendar year
H2 Second six months of the calendar year
JV Partners Joint venture between Origin Energy and Falcon Oil & Gas Australia Ltd.
LNG Liquefied natural gas
MW Megawatt
TOG Group Malcolm John Gerrard, Territory Oil & Gas LLC & Tom Dugan Family Partnership LLC
Stage 2 Drilling operations include the drilling and hydraulic fracture stimulation of two horizontal wells to evaluate the potential of liquids rich gas fairways in the Kyalla and Velkerri shale plays
Stage 3 Drilling operations include the drilling and hydraulic fracture stimulation of two horizontal wells to prove flow rates of gas/liquids that provide a range of commercialisation options
TSXV The TSX Venture Exchange is a stock exchange in Canada

Advisory regarding forward looking statements

Certain information in this press release may constitute forward-looking information. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking information. Forward-looking information typically contains statements with words such as “may”, “will”, “should”, “expect”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “projects”, “dependent”, “potential”, “scheduled”, “forecast”, “outlook”, “budget”, “hope”, “support” or the negative of those terms or similar words suggesting future outcomes.  This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict.  Such information may include, but is not limited to, comments made with respect to the type, number, schedule, stimulating, testing and objectives of the wells to be drilled in the Beetaloo Sub-basin Australia, the prospectivity of the Middle Velkerri and Kyalla plays and the prospect of the exploration programme being brought to commerciality,  risks associated with fluctuations in market prices for shale gas; risks related to the exploration, development and production of shale gas reserves; general economic, market and business conditions; substantial capital requirements; uncertainties inherent in estimating quantities of reserves and resources; extent of, and cost of compliance with, government laws and regulations and the effect of changes in such laws and regulations; the need to obtain regulatory approvals before development commences; environmental risks and hazards and the cost of compliance with environmental regulations; aboriginal claims; inherent risks and hazards with operations such as mechanical or pipe failure, cratering and other dangerous conditions; potential cost overruns, drilling wells is speculative, often involving significant costs that may be more than estimated and may not result in any discoveries; variations in foreign exchange rates; competition for capital, equipment, new leases, pipeline capacity and skilled personnel; the failure of the holder of licenses, leases and permits to meet requirements of such; changes in royalty regimes; failure to accurately estimate abandonment and reclamation costs; inaccurate estimates and assumptions by management and their joint venture partners; effectiveness of internal controls; the potential lack of available drilling equipment; failure to obtain or keep key personnel; title deficiencies; geo-political risks; and risk of litigation.

Readers are cautioned that the foregoing list of important factors is not exhaustive and that these factors and risks are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements.  Falcon assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward looking-statements unless and until required by securities laws applicable to Falcon. Additional information identifying risks and uncertainties is contained in Falcon’s filings with the Canadian securities regulators, which filings are available at www.sedar.com, including under “Risk Factors” in the Annual Information Form.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

COVID-19 Crisis Drives Changes in eCommerce Purchasing Behaviors, ACI Worldwide Research Reveals

COVID-19 Crisis Drives Changes in eCommerce Purchasing Behaviors, ACI Worldwide Research Reveals

DIY products and gardening essentials, laptops and TVs among most popular items bought online

The COVID-19 crisis is driving the global growth of eCommerce sales, with millions of consumers worldwide in quarantine shopping for goods, services and entertainment online. Transaction volumes in most retail sectors have seen a 74 percent rise in March compared to the same period last year, while online gaming has seen a staggering increase of 97 percent, according to analysis by ACI Worldwide of hundreds of millions of transactions from global online retailers.

“During these unprecedented and uncertain times with millions now at home, many consumers are going online to purchase products or services,” said Debbie Guerra, executive vice president, ACI Worldwide. “Quarantine has changed lives for all of us, with consumers buying electronics and furniture—to support work, communication, school and entertainment—as well as items such as home goods and DIY products.”

However, fraud is on the increase too, the research shows, as fraudsters are using the surge in online activity to target unsuspecting consumers and merchants. Merchants are starting to experience dramatic increases in COVID-19-related phishing activities, with stolen credentials released into the eCommerce payments chain, as well as increased friendly fraud activities.

“Fraudulent attempts are on the rise, and consumers must be vigilant as fraudsters are using the current situation to obtain and use their financial data and information,” continued Guerra.

Key Findings:

Online retailer sectors with rising transaction volumes in March 2020 compared to the previous year include:

  • Home products and furnishings: +97 percent, DIY products: +136 percent, Garden essentials: +163 percent, Electronics: +26.6 percent, Telco: +18.6 percent

Online retail sectors with declining transaction volumes in the same period:

  • Ticketing: -60 percent, Travel: -44 percent, Online dating: -8.9 percent

Fraud Trends:

  • Average fraudulent attempted purchase value increased by $36 in March, driven by electronic and retail goods; this corresponds to a fraudulent attempted transactional value increase by 13 percent.
  • Fraudulent attempted transactional volume decreased by 8 percent, driven by increase of fraudulent attempt purchase value.

“Long term, we and others in the industry predict that the shift in consumer behavior—opting for online purchases—is likely to outlast the crisis,” concluded Guerra. “The industry is well ahead of the curve in adapting payment methods and ways to combat fraud in response to the changing behaviors and expectations of consumers, which are now being expedited by the lockdown.”

Tips for Consumers to protect identity and personal information during the COVID-19 crisis:

  • Beware of online requests for personal information. Coronavirus-themed emails seeking personal information are likely to be phishing scams. Legitimate government agencies won’t ask for that information. Delete the email.
  • Check the email address or link. Inspect a link by hovering the mouse button over the URL to see where it leads. Sometimes, it’s obvious the web address is not legitimate. But keep in mind phishers can create links that closely resemble legitimate addresses. Delete the email.
  • Watch for spelling and grammatical mistakes. If an email includes spelling, punctuation and grammar errors, it’s likely a sign of a phishing email. Delete the email.
  • Look for generic greetings. Phishing emails are unlikely to use a person’s name. Greetings like “Dear sir or madam” often signal an email is not legitimate.
  • Avoid emails that insist acting now. Phishing emails often try to create a sense of urgency or demand immediate action. Delete the email.

Tips for Merchants to maintain security and deliver to customers during the COVID-19 crisis:

  • Maintain security and deliver a great customer experience, as consumer purchasing behavior—both genuine and fraudulent—has changed.
    • For example: Express shipment and Buy-Online Pickup In-Store delivery methods in the last two weeks have tripled, making transaction decision speed and accuracy critical.
    • Use customer profiling and time-on-file techniques to maintain the customer experience for valued customers and ensure good transactions are still accepted.
  • Expect an increase in Friendly Fraud Chargebacks as a result of growing financial difficulties among consumers. Friendly fraud occurs when a cardholder receives goods, but denies making a purchase, or a family member makes a purchase without cardholder approval.
    • Monitor systems and update as necessary. Business intelligence tools and real-time monitoring lead to immediate decisions and responses. Employ rapid access to fraud intelligence to inform rules changes in real time.
    • Engage frequently with web and mobile site security management. Give these teams the tools, techniques and procedures to detect, contain and mitigate botnets. And considering the presence of both good and bad bots, put business policies in place to address this issue with clarity for both teams.

About ACI Worldwide

ACI Worldwide, the Universal Payments (UP) company, powers electronic payments for more than 6,000 organizations around the world. More than 1,000 of the largest financial institutions and intermediaries, as well as thousands of global merchants, rely on ACI to execute $14 trillion each day in payments and securities. In addition, myriad organizations utilize our electronic bill presentment and payment services. Through our comprehensive suite of software solutions delivered on customers’ premises or through ACI’s private cloud, we provide real-time, immediate payments capabilities and enable the industry’s most complete omni-channel payments experience. To learn more about ACI, please visit www.aciworldwide.com. You can also find us on Twitter @ACI_Worldwide.

© Copyright ACI Worldwide, Inc. 2020

ACI, ACI Worldwide, the ACI logo, ACI Universal Payments, UP, the UP logo and all ACI product/solution names are trademarks or registered trademarks of ACI Worldwide, Inc., or one of its subsidiaries, in the United States, other countries or both. Other parties’ trademarks referenced are the property of their respective owners.

Dan Ring

E-mail: dan.ring@aciworldwide.com


Katrin Boettger

E-mail: katrin.boettger@aciworldwide.com

Phone:0044 (0)7776 147 910

KEYWORDS: Florida Europe United States United Kingdom North America

INDUSTRY KEYWORDS: Technology Other Retail Finance Security Banking Other Technology Professional Services Data Management Retail Online Retail



Relief Therapeutics (RLF:SIX) Drug Aviptadil Enters FDA Trial at University of Miami, to Treat COVID-19-induced Respiratory Distress

Relief Therapeutics (RLF:SIX) Drug Aviptadil Enters FDA Trial at University of Miami, to Treat COVID-19-induced Respiratory Distress

Aviptadil targets the cytokine storm that causes fatal Respiratory Distress in COVID-19 

  • Coronavirus (COVID-19) death is primarily caused by Acute Respiratory Distress Syndrome (ARDS), in which severe inflammation causes the lungs to fill with fluid and even mechanical ventilation is unable to maintain life. The syndrome is caused by a Cytokine Storm unleashed by viral particles.
  • VIP is known to have potent anti-cytokine effects in numerous animal models and in phase 1 and phase 2 human studies

RELIEF THERAPEUTICS Holding AG (SIX:RLF) “Relief” announces that its drug Aviptadil has now entered FDA clinical trials at the University of Miami Miller School of Medicine for the treatment of Acute Respiratory Distress Syndrome (ARDS) in COVID-19. The trial will enroll patients who are already on mechanical ventilation in the hopes that Aviptadil can decrease mortality in this condition and help to improve the ability of the patient’s lung to transfer oxygen to the body.

The trial is being led by Relief’s US partner, NeuroRx, Inc., Headquartered in Radnor, PA under FDA Investigational New Drug clearance, as part of the FDA’s Corona Treatment Acceleration Program (CTAP). Details are posted on clinicaltrials.gov NCT04311697. The principal investigator for the University of Miami study site is Dr. Dushyantha Jayaweera, professor of medicine. The Co-Principal Investigators are Dr. Daniel H. Kett, professor of medicine, and Dr. Daniel Dante Yeh, associate professor of surgery at the University of Miami Miller School of Medicine. The team will also collaborate with colleagues at the UM Interdisciplinary Stem Cell Institute.

We are fortunate to have widespread support and collaboration across our institution,” said Dr. Jayaweera. “As we follow rigorous scientific standards, we are cautiously optimistic that the early observations of VIP use in patients with sepsis-related ARDS will carry over to today’s crisis.

Death in COVID-19-infected patients is caused by a “cytokine storm” in the lungs, in which the virus triggers inflammatory molecules called “cytokines,” which cause the air sacs (alveolae) of the lungs to fill with water and become impermeable to oxygen, even in the setting of mechanical ventilation. VIP is a naturally synthesized peptide which is 40% concentrated in the lungs and which has been shown to have a potent anti-cytokine activity in numerous animal models of respiratory distress, acute lung injury, and inflammation. It has a 20-year history of safe use in human beings in multiple human trials for sarcoidosis, pulmonary fibrosis, and pulmonary hypertension, and is marketed in Europe as a local injection to treat erectile dysfunction.

Relief Therapeutics holds FDA and EU orphan drug designations for the use of VIP to treat ARDS, pulmonary hypertension, and sarcoidosis. Relief also holds a US patent1 for Aviptadil and proprietary manufacturing processes for its synthesis.

“In a previous trial of VIP for ARDS in patients with sepsis, 7 of 8 patients on mechanical ventilation showed substantial improvement and 6 ultimately left the hospital alive,” said Prof. Jonathan Javitt, MD, MPH, the CEO of NeuroRx, Inc.. “Patients on ventilators for COVID-19 have only a 50% chance of survival. If the early results can be replicated in ARDS caused by COVID-19, this treatment could have a major impact both on COVID-19 survival and on the availability of ventilators for those in desperate need.”


The Relief group of companies focus primarily on clinical-stage projects based on molecules of natural origin (peptides and proteins) with a history of clinical testing and use in human patients or a strong scientific rational. Currently, Relief is concentrating its efforts on developing new treatments for respiratory disease indications.

About RLF-100

RLF-100 (Aviptadil) is a patented formulation of Vasoactive Intestinal Polypeptide (VIP) that was originally developed and is currently marketed in Europe for the treatment of erectile dysfunction. VIP is known to be highly concentrated in the lung and to inhibit a variety of inflammatory cytokines. Aviptadil was awarded Orphan Drug Designation in 2001 by the US FDA for treatment of Acute Respiratory Distress Syndrome and in 2005 for treatment of Pulmonary Arterial Hypertension. Aviptadil was awarded Orphan Drug Designation by the European Medicines Agency in 2006 for the treatment of Acute Lung Injury and in 2007 for the treatment of Sarcoidosis. Both the US FDA and the EMEA have granted Investigational New Drug licenses for human trials of Aviptadil.

RELIEF THERAPEUTICS Holding AG is listed on the SIX Swiss Exchange under the symbol RLF.

Disclaimer: This communication expressly or implicitly contains certain forward-looking statements concerning RELIEF THERAPEUTICS Holding AG, NeuroRx, Inc. and their businesses. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of RELIEF THERAPEUTICS Holding AG and/or NeuroRx, Inc. to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. RELIEF THERAPEUTICS Holding AG is providing this communication as of this date and does not undertake to update any forward looking statements contained herein as a result of new information, future events or otherwise.

1 US 8,178,489 Formulation for Aviptadil


Yves Sagot


KEYWORDS: Florida Europe Switzerland United States North America

INDUSTRY KEYWORDS: FDA Health Infectious Diseases Clinical Trials General Health Biotechnology



DocTalkGo Adds Prescription Thymosin Alpha-1 to Its Roster to Help Boost Immunity in Patients

New York City, New York, April 07, 2020 (GLOBE NEWSWIRE) — It’s more important than ever to build up your immunity and strength in order to fight off contagious, infections diseases such as the coronavirus and influenza. Many consumers have stocked up on natural supplements such as vitamin c, zinc, echinacea and elderberry products to help their immune system remain strengthened. DocTalkGo, a provider of telemedicine based, remote medical services is prescribing an immune building, naturally occurring peptide hormone Thymosin Alpha-1 (Ta1) to approved patients. Thymosin Alpha-1 (Ta1) is in the Thymosin family and is an excellent immune modulator. Thymosin is a peptide produced naturally by the thymus gland and is one of several hormones secreted by the thymus that controls the growth of your T-cells. T-cells are critical when it comes to the body’s immunity responses as is the thymus, where individual T-cells respond to the millions of bacteria, fungi, or viruses that could invade your body.

Thymosin Alpha-1 (Ta1) is most often prescribed for chronic viral diseases but has also been shown to fight against harmful autoimmune processes. It is also used to help control inflammation associated with chronic diseases, which can cause excess fatigue. Thymosin Alpha-1 (Ta1) is a natural occurring peptide hormone that is crucial for the maintenance of homeostasis. It has been chemically synthesized and used in diseases where the immune system is hindered or malfunctioning. Ta1 is very well tolerated, with infrequent and mild adverse reactions. It’s the mostly commonly recommended peptide for general immune modulation. Ta1 may increase T cell function aiding in the body’s natural response to fight off viral and other illnesses. This is very well tolerated and rarely causes any adverse reactions. It is contraindicated in patients with autoimmune disorders or who have had organ transplants.

Schedule a phone or video call with one of DocTalkGo’s licensed health care specialists who can prescribe immunity boosting prescriptions and other remote healthcare services nationwide. If you might be experiencing symptoms of COVID-19, visit https://www.covidmedicaltest.com/  to schedule a same-day consultation by phone or video. If a patient receives a positive COVID-19 test, they could be a candidate for Hydroxycholorquine. In compliance with federal laws, a patient must be tested and receive a positive COVID-19 result before hydroxychloroquine can be prescribed. It cannot be used for preventative measures prior to contracting the coronavirus. Our doctors will determine if COVID-19 symptoms are such that a COVID-19 test is required. If yes, a lab requisition will be sent to the patient to seek local testing.

DocTalkGo is a third party, telemedicine healthcare provider entity providing care nationwide. With a team of doctor and providers, we are available to individuals and families 7 days/week, expanded hours. Same-day, timely consultations always available. DocTalkGo has incorporated a healthcare algorithmn that helps guide the individual through a healthcare screening of questions to determine if that specific healthcare condition or disease management issue is appropriate for telemedicine care or should be directed back to an in-person doctor visit. 

DocTalkGo healthcare providers are able to do nationwide laboratory testing and prescription submission to a pharmacy of the patient’s choice. 


Contact information:










Julie Wright